arrow
D

Daniel Faurholt-Jepsen

University of Copenhagen
H指数:27
被引数:2,713

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Early antimicrobial therapy and clinical outcomes of left-sided Enterococcus faecalis endocarditis: a NIDUS registry study

左心侧粪肠球菌心内膜炎的早期抗菌治疗与临床结局:一项NIDUS注册研究

2026-10-030
OA
Associations between prior wasting malnutrition and indices of insulin secretion and sensitivity among six cohorts from Asia and Africa: The SAMPA study

亚洲和非洲六个队列中既往消瘦性营养不良与胰岛素分泌和敏感性指标之间的关联:SAMPA研究

2026-09-290
OAAI
Characteristics and outcomes of patients with possible versus definite infective endocarditis: A nationwide cohort study from the NIDUS Database

可能感染性心内膜炎与确诊感染性心内膜炎患者的特征及结局:一项来自NIDUS数据库的国家队列研究

2026-07-010
OAAI
Bone health after 3 years of ETI therapy: a real-world study from the Danish cystic fibrosis cohort

ETI疗法3年后的骨骼健康:一项来自丹麦囊性纤维化队列的真实世界研究

2026-02-180
PRE
Dynamic changes in circulating microRNAs during oral glucose tolerance testing support their potential as diagnostic and monitoring biomarkers in cystic fibrosis-related diabetes

在口服葡萄糖耐量试验期间循环microRNAs的动态变化,支持其作为囊性纤维化相关糖尿病诊断和监测生物标志物的潜力。

2026-01-070
OAAI
Vitamin D Deficiency at Hospital Admission With Community-Acquired Pneumonia is Associated With Increased Risk of Mortality: A Prospective Cohort Study

社区获得性肺炎住院患者维生素D缺乏与死亡风险增加相关:一项前瞻性队列研究

2025-12-010
OAAI
Body mass, linear growth, and body composition before and after the introduction of elexacaftor/tezacaftor/ivacaftor among children and adults with cystic fibrosis

在囊性纤维化患儿和成人中,引入elexacaftor/tezacaftor/ivacaftor前后,体重、线性生长和体成分的变化。

2025-09-240
PREAI
Severe hepatotoxicity is uncommon following the introduction of Elexacaftor/Tezacaftor/Ivacaftor: A real-world two-years follow-up study of the Danish cystic fibrosis cohort

Elexacaftor/Tezacaftor/Ivacaftor引入后严重肝毒性不常见:一项针对丹麦囊性纤维化队列的真实世界两年随访研究

2025-08-250
OAAI
Associations of prior wasting malnutrition with later indicators of glucose tolerance across four countries in Africa and Asia: the SAMPA cohort study

前期消瘦型营养不良与后期葡萄糖耐量指标的关联:基于非洲和亚洲四个国家SAMPA队列研究

2025-08-050
OAAI
Hyperglycemia and insulin use in patients with COVID-19 and severe hypoxemia allocated to 12 mg vs. 6 mg of dexamethasone: a secondary analysis of the COVID STEROID 2 randomized trial

高血糖和胰岛素使用在COVID-19合并严重低氧血症患者中分配接受12 mg与6 mg地塞米松的情况:COVID STEROID 2随机试验的二次分析

2025-07-150
OAAI
Patient characteristics, presentation, causal microorganisms, and overall mortality in the NatIonal Danish endocarditis stUdieS (NIDUS) registry
2025-02-010
OAAI